Literature DB >> 11122758

Endothelial function as a therapeutic target in coronary artery disease.

N Sharma1, T C Andrews.   

Abstract

In healthy individuals, endothelial cells regulate a host of functions including vasomotor tone, thrombosis/ fibrinolysis, and cell-cell interactions. The development of endothelial dysfunction may be a common pathway by which cardiovascular risk factors impact plaque formation, growth, and rupture. Many pharmacologic and nonpharmacologic interventions known to decrease cardiovascular risk also improve endothelial function. For these reasons, some have suggested that improvement in endothelial function may be an important therapeutic target in the treatment of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122758     DOI: 10.1007/s11883-000-0063-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  33 in total

1.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.

Authors: 
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

Authors:  G O'Driscoll; D Green; R R Taylor
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

4.  Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.

Authors:  D E Vaughan; J L Rouleau; P M Ridker; J M Arnold; F J Menapace; M A Pfeffer
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

5.  Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.

Authors:  L Cashin-Hemphill; G Holmvang; R C Chan; B Pitt; R E Dinsmore; R S Lees
Journal:  Am J Cardiol       Date:  1999-01-01       Impact factor: 2.778

6.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  M St John Sutton; M A Pfeffer; L Moye; T Plappert; J L Rouleau; G Lamas; J Rouleau; J O Parker; M O Arnold; B Sussex; E Braunwald
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

7.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

8.  Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

Authors:  P J Nahser; R E Brown; H Oskarsson; M D Winniford; J D Rossen
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

9.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

Authors:  T J Anderson; I T Meredith; A C Yeung; B Frei; A P Selwyn; P Ganz
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

10.  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

View more
  4 in total

Review 1.  Effect of diet on vascular reactivity: an emerging marker for vascular risk.

Authors:  S G West
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

Review 2.  Diagnosis and treatment of hyperhomocysteinemia.

Authors:  M E Keebler; C De Souza ; V Fonseca
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

3.  Influence of dietary saturated fat intake on endothelial fibrinolytic capacity in adults.

Authors:  Caitlin A Dow; Brian L Stauffer; Jared J Greiner; Christopher A DeSouza
Journal:  Am J Cardiol       Date:  2014-06-19       Impact factor: 2.778

4.  Noninvasive Investigation of the Presence and Extent of Coronary Artery Disease by the Evaluation of Fingertip-Reactive Hyperemia.

Authors:  Sefik Gorkem Fatihoglu; Farzin Jam; Sercan Okutucu; Ali Oto
Journal:  Med Princ Pract       Date:  2022-01-20       Impact factor: 2.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.